Can a diabetes pill fix antipsychotic weight gain? new trial aims to find out.
NCT ID NCT05669742
First seen Feb 06, 2026 · Last updated May 23, 2026 · Updated 16 times
Summary
This study tests whether adding empagliflozin, a diabetes drug, can reduce weight gain and other metabolic problems caused by olanzapine in people with schizophrenia. About 40 adults aged 18–60 who take olanzapine will receive either empagliflozin or a placebo for several weeks. The main goal is to see if the drug helps control body weight and blood sugar without causing serious side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SODIUM-GLUCOSE TRANSPORT PROTEIN TWO INHIBITOR (SGLT2),METABOLIC DEFICITS CAUSED BY ANTIPSYCHOTICS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Tanta Unuversity
RECRUITINGTanta, 34518, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.